Lymeclon 408 Capsule contains Lymecycline 408 mg, a broad-spectrum tetracycline-class antibiotic that inhibits bacterial protein synthesis, preventing growth and replication of susceptible bacteria. It offers effective bacteriostatic activity against a wide range of Gram-positive and Gram-negative pathogens.
Clinically, Lymeclon 408 Capsule is indicated for respiratory tract infections, urinary tract infections, acne, skin and soft tissue infections, and other bacterial infections. Its higher dosage ensures enhanced therapeutic efficacy, particularly in moderate to severe infections requiring intensive antibiotic therapy.
The capsule formulation ensures accurate dosing, consistent bioavailability, and reliable clinical outcomes, making it suitable for hospitals, dermatology and general clinics, specialty pharmacies, and institutional supply chains. Its convenient oral administration supports patient compliance and optimal treatment adherence.
Lymeclon 408 Capsule also helps prevent infection-related complications, reduce recurrence rates, and support overall public health by effectively controlling bacterial infections. Its safe, evidence-based, and high-quality formulation makes it a trusted choice for healthcare providers managing a broad spectrum of bacterial diseases.